UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 304

Sortiert nach

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative

Annals of oncology, 2010-03, Vol.21 (3), p.615-626

2010

Link zum Volltext

Verfügbarkeit prüfen

ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii143-iii152

Cherny, N I

2014

Link zum Volltext

Verfügbarkeit prüfen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: a report from the Global Opioid Policy Initiative (GOPI)

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi24-xi32

2013

Link zum Volltext

Verfügbarkeit prüfen

ESMO-Magnitude of Clinical Benefit Scale version 1.1

Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366

2017

Link zum Volltext

Verfügbarkeit prüfen

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Annals of oncology, 2015-08, Vol.26 (8), p.1547-1573

2015

Link zum Volltext

Verfügbarkeit prüfen

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe

Annals of oncology, 2017-11, Vol.28 (11), p.2633-2647

2017

Link zum Volltext

Verfügbarkeit prüfen

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

ESMO open, 2022-02, Vol.7 (1), p.100379-100379, Article 100379

2022

Link zum Volltext

Verfügbarkeit prüfen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI)

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi33-xi40

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv111-iv125

2018

Link zum Volltext

Verfügbarkeit prüfen

ESMO Clinical Practice Guidelines on palliative care: advanced care planning

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii138-iii142

2014

Link zum Volltext

Verfügbarkeit prüfen

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv126-iv142

2018

Link zum Volltext

Verfügbarkeit prüfen

The management of cancer pain

CA: a cancer journal for clinicians, 2000-03, Vol.50 (2), p.70-116

Cherny, N. I

2000

Link zum Volltext

Verfügbarkeit prüfen

The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi7-xi13

2013

Link zum Volltext

Verfügbarkeit prüfen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi51-xi59

2013

Link zum Volltext

Verfügbarkeit prüfen

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

Annals of oncology, 2023-04, Vol.34 (4), p.431-439

2023

Link zum Volltext

Verfügbarkeit prüfen

When is off-label off-road?

Annals of oncology, 2019-10, Vol.30 (10), p.1536-1538

2019

Link zum Volltext

Verfügbarkeit prüfen

How to deal with difficult pain problems

Annals of oncology, 2005-01, Vol.16 (suppl-2), p.ii79-ii87

Cherny, N.I.

2005

Link zum Volltext

Verfügbarkeit prüfen

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Annals of oncology, 2017-11, Vol.28 (11), p.2901-2905

2017

Link zum Volltext

Verfügbarkeit prüfen

Opioid analgesics : Comparative features and prescribing guidelines

Drugs (New York, N.Y.), 1996-05, Vol.51 (5), p.713-737

CHERNY, N. I

1996

Link zum Volltext

Verfügbarkeit prüfen

Next steps in access and availability of opioids for the treatment of cancer pain: reaching the tipping point?

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi60-xi64

2013

Link zum Volltext

Verfügbarkeit prüfen

ESMO takes a stand on supportive and palliative care

Annals of oncology, 2003-09, Vol.14 (9), p.1335-1337

2003

Link zum Volltext

Verfügbarkeit prüfen

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Annals of oncology, 2023-09, Vol.34 (9), p.734-771

2023

Link zum Volltext

Verfügbarkeit prüfen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI)

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi14-xi23

2013

Link zum Volltext

Verfügbarkeit prüfen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI)

Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi41-xi50

2013

Link zum Volltext

Verfügbarkeit prüfen

When is off-label off-road?

Annals of oncology, 2019-12, Vol.30 (12), p.2018-2018

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Englisch
(289)
Japanisch
(23)
Russisch
(20)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative

ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: a report from the Global Opioid Policy Initiative (GOPI)

ESMO-Magnitude of Clinical Benefit Scale version 1.1

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI)

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines

ESMO Clinical Practice Guidelines on palliative care: advanced care planning

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

The management of cancer pain

The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

When is off-label off-road?

How to deal with difficult pain problems

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Opioid analgesics : Comparative features and prescribing guidelines

Next steps in access and availability of opioids for the treatment of cancer pain: reaching the tipping point?

ESMO takes a stand on supportive and palliative care

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI)

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI)

When is off-label off-road?

Suchergebnisse filtern